Triangle Securities Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$431K Buy
+3,410
New +$449K 0.09% 169
2017
Q2
Sell
-3,832
Closed -$260K 129
2017
Q1
$260K Buy
3,832
+895
+30% +$62.9K 0.17% 115
2016
Q4
$210K Sell
2,937
-3,430
-54% -$255K 0.14% 121
2016
Q3
$504K Sell
6,367
-950
-13% -$77.2K 0.35% 81
2016
Q2
$610K Sell
7,317
-580
-7% -$51.5K 0.46% 68
2016
Q1
$725K Sell
7,897
-20
-0.3% -$1.8K 0.47% 68
2015
Q4
$801K Sell
7,917
-125
-2% -$13K 0.54% 61
2015
Q3
$790K Sell
8,042
-380
-5% -$42.2K 0.6% 54
2015
Q2
$986K Sell
8,422
-465
-5% -$50.8K 0.7% 47
2015
Q1
$872K Sell
8,887
-3
-0% -$305 0.6% 56
2014
Q4
$838K Sell
8,890
-850
-9% -$87.9K 0.6% 57
2014
Q3
$1.04M Sell
9,740
-400
-4% -$39.2K 0.8% 46
2014
Q2
$841K Buy
+10,140
New +$789K 0.64% 59
2013
Q3
Sell
-1,500
Closed -$77K 219
2013
Q2
$77K Buy
+1,500
New +$78.2K 0.06% 198

Other funds holding GILD

Triangle Securities Wealth Management's GILD Position: Q2 2026 in Review

Triangle Securities Wealth Management opened a new position in Gilead Sciences (GILD) in Q2 2026: 3,410 shares worth $431K. The stake represents 0.09% of the portfolio and ranks #169 among its holdings. This is a return to the name: Triangle Securities Wealth Management previously reported a position in GILD as recently as Q1 2017.

Triangle Securities Wealth Management first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. The position peaked at $1.04M in Q3 2014. 428 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Triangle Securities Wealth Management held 3,410 shares of Gilead Sciences worth $431K as of Q2 2026.
  • Gilead Sciences was a new Triangle Securities Wealth Management position in Q2 2026.
  • Gilead Sciences made up 0.09% of Triangle Securities Wealth Management's portfolio in Q2 2026, its #169 holding.
  • Triangle Securities Wealth Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
  • Triangle Securities Wealth Management's Gilead Sciences position peaked at $1.04M in Q3 2014.
  • 428 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Triangle Securities Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.